Global Localized Autoimmune Disease Diagnostics Market Size, Status and Forecast 2020-2026

May 2020 | 96 pages | ID: G84EA9FE4F78EN
QYResearch

Abstracts

This report focuses on the global Localized Autoimmune Disease Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Localized Autoimmune Disease Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Hoffmann-La Roche Ltd
• Siemens Healthineers
• Abbott Laboratories
• Beckman Coulter, Inc.
• SQI Diagnostics
• Quest Diagnostics
• EUROIMMUN AG
• AESKU.Diagnostics GmbH & Co. KG
• INOVA Diagnostics, Inc.
• Crescendo Bioscience, Inc.
• bioMerieux SA
• Bio-Rad Laboratories, Inc.
• Hemagen Diagnostics, Inc.

Market segment by Type, the product can be split into

• Multiple Sclerosis
• Type 1 Diabetes
• Hashimoto's Thyroiditis
• Idiopathic Thrombocytopenic Purpura
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Research Institute
• Laboratories

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Localized Autoimmune Disease Diagnostics status, future forecast, growth opportunity, key market and key players.
• To present the Localized Autoimmune Disease Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Localized Autoimmune Disease Diagnostics are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Localized Autoimmune Disease Diagnostics Revenue
1.4 Market Analysis by Type
  1.4.1 Global Localized Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Multiple Sclerosis
  1.4.3 Type 1 Diabetes
  1.4.4 Hashimoto's Thyroiditis
  1.4.5 Idiopathic Thrombocytopenic Purpura
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Localized Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Research Institute
  1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Localized Autoimmune Disease Diagnostics Market Perspective (2015-2026)
2.2 Localized Autoimmune Disease Diagnostics Growth Trends by Regions
  2.2.1 Localized Autoimmune Disease Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Localized Autoimmune Disease Diagnostics Historic Market Share by Regions (2015-2020)
  2.2.3 Localized Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Localized Autoimmune Disease Diagnostics Market Growth Strategy
  2.3.6 Primary Interviews with Key Localized Autoimmune Disease Diagnostics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Localized Autoimmune Disease Diagnostics Players by Market Size
  3.1.1 Global Top Localized Autoimmune Disease Diagnostics Players by Revenue (2015-2020)
  3.1.2 Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Players (2015-2020)
  3.1.3 Global Localized Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Localized Autoimmune Disease Diagnostics Market Concentration Ratio
  3.2.1 Global Localized Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Localized Autoimmune Disease Diagnostics Revenue in 2019
3.3 Localized Autoimmune Disease Diagnostics Key Players Head office and Area Served
3.4 Key Players Localized Autoimmune Disease Diagnostics Product Solution and Service
3.5 Date of Enter into Localized Autoimmune Disease Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Localized Autoimmune Disease Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Localized Autoimmune Disease Diagnostics Forecasted Market Size by Type (2021-2026)

5 LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)
5.2 Global Localized Autoimmune Disease Diagnostics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
6.2 Localized Autoimmune Disease Diagnostics Key Players in North America (2019-2020)
6.3 North America Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
6.4 North America Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
7.2 Localized Autoimmune Disease Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
7.4 Europe Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

8 CHINA

8.1 China Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
8.2 Localized Autoimmune Disease Diagnostics Key Players in China (2019-2020)
8.3 China Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
8.4 China Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
9.2 Localized Autoimmune Disease Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
9.4 Japan Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
10.2 Localized Autoimmune Disease Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

11 INDIA

11.1 India Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
11.2 Localized Autoimmune Disease Diagnostics Key Players in India (2019-2020)
11.3 India Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
11.4 India Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Localized Autoimmune Disease Diagnostics Market Size (2015-2020)
12.2 Localized Autoimmune Disease Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Hoffmann-La Roche Ltd
  13.1.1 Hoffmann-La Roche Ltd Company Details
  13.1.2 Hoffmann-La Roche Ltd Business Overview and Its Total Revenue
  13.1.3 Hoffmann-La Roche Ltd Localized Autoimmune Disease Diagnostics Introduction
  13.1.4 Hoffmann-La Roche Ltd Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020))
  13.1.5 Hoffmann-La Roche Ltd Recent Development
13.2 Siemens Healthineers
  13.2.1 Siemens Healthineers Company Details
  13.2.2 Siemens Healthineers Business Overview and Its Total Revenue
  13.2.3 Siemens Healthineers Localized Autoimmune Disease Diagnostics Introduction
  13.2.4 Siemens Healthineers Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.2.5 Siemens Healthineers Recent Development
13.3 Abbott Laboratories
  13.3.1 Abbott Laboratories Company Details
  13.3.2 Abbott Laboratories Business Overview and Its Total Revenue
  13.3.3 Abbott Laboratories Localized Autoimmune Disease Diagnostics Introduction
  13.3.4 Abbott Laboratories Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.3.5 Abbott Laboratories Recent Development
13.4 Beckman Coulter, Inc.
  13.4.1 Beckman Coulter, Inc. Company Details
  13.4.2 Beckman Coulter, Inc. Business Overview and Its Total Revenue
  13.4.3 Beckman Coulter, Inc. Localized Autoimmune Disease Diagnostics Introduction
  13.4.4 Beckman Coulter, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.4.5 Beckman Coulter, Inc. Recent Development
13.5 SQI Diagnostics
  13.5.1 SQI Diagnostics Company Details
  13.5.2 SQI Diagnostics Business Overview and Its Total Revenue
  13.5.3 SQI Diagnostics Localized Autoimmune Disease Diagnostics Introduction
  13.5.4 SQI Diagnostics Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.5.5 SQI Diagnostics Recent Development
13.6 Quest Diagnostics
  13.6.1 Quest Diagnostics Company Details
  13.6.2 Quest Diagnostics Business Overview and Its Total Revenue
  13.6.3 Quest Diagnostics Localized Autoimmune Disease Diagnostics Introduction
  13.6.4 Quest Diagnostics Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.6.5 Quest Diagnostics Recent Development
13.7 EUROIMMUN AG
  13.7.1 EUROIMMUN AG Company Details
  13.7.2 EUROIMMUN AG Business Overview and Its Total Revenue
  13.7.3 EUROIMMUN AG Localized Autoimmune Disease Diagnostics Introduction
  13.7.4 EUROIMMUN AG Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.7.5 EUROIMMUN AG Recent Development
13.8 AESKU.Diagnostics GmbH & Co. KG
  13.8.1 AESKU.Diagnostics GmbH & Co. KG Company Details
  13.8.2 AESKU.Diagnostics GmbH & Co. KG Business Overview and Its Total Revenue
  13.8.3 AESKU.Diagnostics GmbH & Co. KG Localized Autoimmune Disease Diagnostics Introduction
  13.8.4 AESKU.Diagnostics GmbH & Co. KG Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.8.5 AESKU.Diagnostics GmbH & Co. KG Recent Development
13.9 INOVA Diagnostics, Inc.
  13.9.1 INOVA Diagnostics, Inc. Company Details
  13.9.2 INOVA Diagnostics, Inc. Business Overview and Its Total Revenue
  13.9.3 INOVA Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Introduction
  13.9.4 INOVA Diagnostics, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.9.5 INOVA Diagnostics, Inc. Recent Development
13.10 Crescendo Bioscience, Inc.
  13.10.1 Crescendo Bioscience, Inc. Company Details
  13.10.2 Crescendo Bioscience, Inc. Business Overview and Its Total Revenue
  13.10.3 Crescendo Bioscience, Inc. Localized Autoimmune Disease Diagnostics Introduction
  13.10.4 Crescendo Bioscience, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  13.10.5 Crescendo Bioscience, Inc. Recent Development
13.11 bioMerieux SA
  10.11.1 bioMerieux SA Company Details
  10.11.2 bioMerieux SA Business Overview and Its Total Revenue
  10.11.3 bioMerieux SA Localized Autoimmune Disease Diagnostics Introduction
  10.11.4 bioMerieux SA Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  10.11.5 bioMerieux SA Recent Development
13.12 Bio-Rad Laboratories, Inc.
  10.12.1 Bio-Rad Laboratories, Inc. Company Details
  10.12.2 Bio-Rad Laboratories, Inc. Business Overview and Its Total Revenue
  10.12.3 Bio-Rad Laboratories, Inc. Localized Autoimmune Disease Diagnostics Introduction
  10.12.4 Bio-Rad Laboratories, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  10.12.5 Bio-Rad Laboratories, Inc. Recent Development
13.13 Hemagen Diagnostics, Inc.
  10.13.1 Hemagen Diagnostics, Inc. Company Details
  10.13.2 Hemagen Diagnostics, Inc. Business Overview and Its Total Revenue
  10.13.3 Hemagen Diagnostics, Inc. Localized Autoimmune Disease Diagnostics Introduction
  10.13.4 Hemagen Diagnostics, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020)
  10.13.5 Hemagen Diagnostics, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Localized Autoimmune Disease Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Localized Autoimmune Disease Diagnostics Revenue
Table 3. Ranking of Global Top Localized Autoimmune Disease Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Localized Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Multiple Sclerosis
Table 6. Key Players of Type 1 Diabetes
Table 7. Key Players of Hashimoto's Thyroiditis
Table 8. Key Players of Idiopathic Thrombocytopenic Purpura
Table 9. Key Players of Others
Table 10. Global Localized Autoimmune Disease Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Localized Autoimmune Disease Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Localized Autoimmune Disease Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Localized Autoimmune Disease Diagnostics Market Share by Regions (2015-2020)
Table 14. Global Localized Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Localized Autoimmune Disease Diagnostics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Localized Autoimmune Disease Diagnostics Market Growth Strategy
Table 20. Main Points Interviewed from Key Localized Autoimmune Disease Diagnostics Players
Table 21. Global Localized Autoimmune Disease Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 22. Global Localized Autoimmune Disease Diagnostics Market Share by Players (2015-2020)
Table 23. Global Top Localized Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Localized Autoimmune Disease Diagnostics as of 2019)
Table 24. Global Localized Autoimmune Disease Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Localized Autoimmune Disease Diagnostics Product Solution and Service
Table 27. Date of Enter into Localized Autoimmune Disease Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 30. Global Localized Autoimmune Disease Diagnostics Market Size Share by Type (2015-2020)
Table 31. Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Type (2021-2026)
Table 32. Global Localized Autoimmune Disease Diagnostics Market Size Share by Application (2015-2020)
Table 33. Global Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 34. Global Localized Autoimmune Disease Diagnostics Market Size Share by Application (2021-2026)
Table 35. North America Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 37. North America Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 38. North America Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 39. North America Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 40. North America Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 41. Europe Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 43. Europe Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 45. Europe Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 47. China Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 48. China Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 49. China Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 50. China Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 51. China Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 52. China Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 53. Japan Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 55. Japan Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 57. Japan Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 61. Southeast Asia Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 63. Southeast Asia Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 65. India Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 66. India Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 67. India Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 68. India Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 69. India Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 70. India Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Localized Autoimmune Disease Diagnostics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Localized Autoimmune Disease Diagnostics Market Share (2019-2020)
Table 73. Central & South America Localized Autoimmune Disease Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Localized Autoimmune Disease Diagnostics Market Share by Type (2015-2020)
Table 75. Central & South America Localized Autoimmune Disease Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Localized Autoimmune Disease Diagnostics Market Share by Application (2015-2020)
Table 77. Hoffmann-La Roche Ltd Company Details
Table 78. Hoffmann-La Roche Ltd Business Overview
Table 79. Hoffmann-La Roche Ltd Product
Table 80. Hoffmann-La Roche Ltd Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 81. Hoffmann-La Roche Ltd Recent Development
Table 82. Siemens Healthineers Company Details
Table 83. Siemens Healthineers Business Overview
Table 84. Siemens Healthineers Product
Table 85. Siemens Healthineers Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 86. Siemens Healthineers Recent Development
Table 87. Abbott Laboratories Company Details
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Product
Table 90. Abbott Laboratories Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 91. Abbott Laboratories Recent Development
Table 92. Beckman Coulter, Inc. Company Details
Table 93. Beckman Coulter, Inc. Business Overview
Table 94. Beckman Coulter, Inc. Product
Table 95. Beckman Coulter, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 96. Beckman Coulter, Inc. Recent Development
Table 97. SQI Diagnostics Company Details
Table 98. SQI Diagnostics Business Overview
Table 99. SQI Diagnostics Product
Table 100. SQI Diagnostics Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 101. SQI Diagnostics Recent Development
Table 102. Quest Diagnostics Company Details
Table 103. Quest Diagnostics Business Overview
Table 104. Quest Diagnostics Product
Table 105. Quest Diagnostics Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 106. Quest Diagnostics Recent Development
Table 107. EUROIMMUN AG Company Details
Table 108. EUROIMMUN AG Business Overview
Table 109. EUROIMMUN AG Product
Table 110. EUROIMMUN AG Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 111. EUROIMMUN AG Recent Development
Table 112. AESKU.Diagnostics GmbH & Co. KG Business Overview
Table 113. AESKU.Diagnostics GmbH & Co. KG Product
Table 114. AESKU.Diagnostics GmbH & Co. KG Company Details
Table 115. AESKU.Diagnostics GmbH & Co. KG Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 116. AESKU.Diagnostics GmbH & Co. KG Recent Development
Table 117. INOVA Diagnostics, Inc. Company Details
Table 118. INOVA Diagnostics, Inc. Business Overview
Table 119. INOVA Diagnostics, Inc. Product
Table 120. INOVA Diagnostics, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 121. INOVA Diagnostics, Inc. Recent Development
Table 122. Crescendo Bioscience, Inc. Company Details
Table 123. Crescendo Bioscience, Inc. Business Overview
Table 124. Crescendo Bioscience, Inc. Product
Table 125. Crescendo Bioscience, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 126. Crescendo Bioscience, Inc. Recent Development
Table 127. bioMerieux SA Company Details
Table 128. bioMerieux SA Business Overview
Table 129. bioMerieux SA Product
Table 130. bioMerieux SA Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 131. bioMerieux SA Recent Development
Table 132. Bio-Rad Laboratories, Inc. Company Details
Table 133. Bio-Rad Laboratories, Inc. Business Overview
Table 134. Bio-Rad Laboratories, Inc. Product
Table 135. Bio-Rad Laboratories, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 136. Bio-Rad Laboratories, Inc. Recent Development
Table 137. Hemagen Diagnostics, Inc. Company Details
Table 138. Hemagen Diagnostics, Inc. Business Overview
Table 139. Hemagen Diagnostics, Inc. Product
Table 140. Hemagen Diagnostics, Inc. Revenue in Localized Autoimmune Disease Diagnostics Business (2015-2020) (Million US$)
Table 141. Hemagen Diagnostics, Inc. Recent Development
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Localized Autoimmune Disease Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Multiple Sclerosis Features
Figure 3. Type 1 Diabetes Features
Figure 4. Hashimoto's Thyroiditis Features
Figure 5. Idiopathic Thrombocytopenic Purpura Features
Figure 6. Others Features
Figure 7. Global Localized Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Localized Autoimmune Disease Diagnostics Report Years Considered
Figure 13. Global Localized Autoimmune Disease Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Localized Autoimmune Disease Diagnostics Market Share by Regions: 2020 VS 2026
Figure 15. Global Localized Autoimmune Disease Diagnostics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Localized Autoimmune Disease Diagnostics Market Share by Players in 2019
Figure 18. Global Top Localized Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Localized Autoimmune Disease Diagnostics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Localized Autoimmune Disease Diagnostics Revenue in 2019
Figure 20. North America Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Localized Autoimmune Disease Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Hoffmann-La Roche Ltd Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 29. Siemens Healthineers Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Siemens Healthineers Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 31. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Abbott Laboratories Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 33. Beckman Coulter, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Beckman Coulter, Inc. Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 35. SQI Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. SQI Diagnostics Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 37. Quest Diagnostics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Quest Diagnostics Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 39. EUROIMMUN AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. EUROIMMUN AG Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 41. AESKU.Diagnostics GmbH & Co. KG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. AESKU.Diagnostics GmbH & Co. KG Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 43. INOVA Diagnostics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. INOVA Diagnostics, Inc. Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 45. Crescendo Bioscience, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Crescendo Bioscience, Inc. Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 47. bioMerieux SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. bioMerieux SA Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 49. Bio-Rad Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bio-Rad Laboratories, Inc. Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 51. Hemagen Diagnostics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Hemagen Diagnostics, Inc. Revenue Growth Rate in Localized Autoimmune Disease Diagnostics Business (2015-2020)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed